ONE Savings Bank PLC : Director/PDMR Shareholding

29.March 2016 at 16:38:00 CET

OneSavings Bank plc
(the 'Company')

Directors' Dealings

The Company announces that:

On 29 March 2016 it received notification that, on 23 March 2016 Mr Stephan Wilcke, a Non-Executive Director of the Company, sold 250,000 ordinary shares in the Company at an aggregate price of 311.522 pence per share.

Following this transaction Mr Wilcke is interested in 50,000 ordinary shares in OneSavings Bank plc, representing 0.02 per cent of the ordinary shares in issue.

For further information contact:


OneSavings Bank plc
Alastair Pate, Head of Investor Relations            t: 01634 838973

Brunswick                                                        t:  020 7404 5959
Michael Harrison / Robin Wrench / Craig Breheny / Simone Selzer

Notes to Editors

About OneSavings Bank plc

OneSavings Bank plc ('OSB') began trading as a bank on 1 February 2011 when the trade and assets of Kent Reliance Building Society ('KRBS') were transferred into the business. OSB is a specialist lending and retail savings group authorised by the Prudential Regulation Authority, part of the Bank of England, and regulated by the Financial Conduct Authority and Prudential Regulation Authority.

OSB focuses on selected sub-sectors of the lending market in which it has established expertise, platforms and capabilities, and where opportunities have been identified for both high returns on a risk-adjusted basis and strong growth. These include Residential Mortgages (comprising first charge, second charge and shared ownership), Buy-to-Let/SME and Personal Loans. OSB originates organically through specialist brokers and independent financial advisors.

OSB is predominantly funded by retail savings originated through the established Kent Reliance franchise, which includes a network of branches in the South East of England, as well as online and postal channels. Diversification of funding is currently provided by a securitisation and OSB joined the Funding for Lending Scheme in early 2014.